Özge Özkaya, PhD, —
Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Articles by Özge Özkaya
Recent Posts
- Telitacicept eases Sjögren’s disease activity in Phase 3 trial
- Machine learning tool may help in diagnosing primary Sjögren’s
- Problems due to Sjögren’s found to reduce women’s quality of life
- Rise’s R-2487 moves toward clinical testing as Sjögren’s treatment
- Outcomes from Sjögren’s-associated lung disease worse in men: Study
- B-cells containing CD226 may be Sjögren’s biomarker, therapy target
- Traditional Chinese medicine QJZG may help ease Sjögren’s disease
- Sjögren’s name change marks it as ‘serious autoimmune disease’
- Telitacicept shows promise for primary Sjögren’s in Phase 3 trial
- Safety, efficacy seen for Sjögren’s therapy ianalumab in pair of trials